Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ATP synthase 6 pseudogene (MTATP6P1) is a segment of nuclear DNA in humans homologous to the mitochondrial MT-ATP6 gene, which encodes an essential subunit of mitochondrial ATP synthase complex V. As a pseudogene, MTATP6P1 does not produce a functional protein, is not involved in cellular bioenergetics, and is not associated with disease or drug targeting. Functional MT-ATP6 (not the pseudogene) encodes a core subunit of the F_o domain in ATP synthase, crucial for ATP generation in mitochondria; mutations in the true MT-ATP6 cause severe mitochondrial disorders such as Leigh syndrome and NARP syndrome. Important distinction: While the functional MT-ATP6 is a critical mitochondrial enzyme component and a genuine disease gene and potential target, the pseudogene (MTATP6P1, ATP synthase 6 pseudogene, ENSG00000234604) is not a functional molecule, enzyme, receptor, or therapeutic target. Its classification as a pseudogene means it does not participate in any regular cellular, molecular, or disease processes and is excluded from therapeutic consideration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase membrane subunit 6, pseudogene (MTATP6P1).